Cocrystal Pharma, Inc.COCPNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank71
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P71
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2024-12.40%
202331.58%
2022-68.53%
2021-29.39%
2020-528.92%
201981.15%
2018-20.09%
201752.90%
2016-42.05%
2015-71.69%